Higher Drug Exposure During the First 24 Weeks of Ustekinumab Treatment Is Associated With Endoscopic Remission in Crohn's Disease

被引：2

作者：

Berghe, Nathalie Van Den ^{[1
]}

Verstockt, Bram ^{[2
]}

Vermeire, Severine ^{[2
]}

Thomas, Debby ^{[1
,3
]}

Declerck, Paul ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Therapeut & Diagnost Antibodies, Leuven, Belgium

[2] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Dept Chron Dis & Metab, Translat Res Gastrointestinal Disorders, Leuven, Belgium

[3] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Campus Gasthuisberg O&N2,PB 820,Herestr 49, B-3000 Leuven, Belgium

来源：

关键词：

INDUCTION; THERAPY;

D O I：

10.1016/j.cgh.2021.12.020

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：838 / +

页数：5